Correspondence (reply): In Reply

Por Laack, Eckart
Publicado em 2008

Adjuvant Chemotherapy After Complete Resection of Non-Small Cell Lung Cancer

Por Laack, Eckart, Bokemeyer, Carsten, Hossfeld, Dieter Kurt
Publicado em 2008

Lectin Histochemistry of Resected Adenocarcinoma of the Lung : Helix pomatia Agglutinin Binding Is an Independent Prognostic Factor

Por Laack, Eckart, Nikbakht, Haleh, Peters, Anja, Kugler, Christian, Jasiewicz, Yvonne, Edler, Lutz, Hossfeld, Dieter Kurt, Schumacher, Udo
Publicado em 2002

Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib

Por Schuler, Martin, Fischer, Jürgen R., Grohé, Christian, Gütz, Sylvia, Thomas, Michael, Kimmich, Martin, Schneider, Claus-Peter, Laack, Eckart, Märten, Angela
Publicado em 2014

PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction Treatment with Pemetrexed Pl...

Por Reck, Martin, Paz-Ares, Luis G., de Marinis, Filippo, Molinier, Olivier, Sahoo, Tarini Prasad, Laack, Eckart, John, William, Zimmermann, Annamaria H., Visseren-Grul, Carla, Gridelli, Cesare
Publicado em 2014